Synergy between PEDF and Doxorubicin in Breast Cancer Cells: Effects on Metastatic and Metabolic PathwaysRaziyeh Abooshahab(Curtin University), Crispin R. Dass(Curtin University)International Journal of Molecular SciencesFebruary 27, 202410.3390/ijms25052755Cited by 6SaveCiteExport RISWatch citationsRelated PapersPigment Epithelium-Derived Factor: Inhibition of Phosphorylation of Insulin Receptor (IR)/IR Substrate (IRS), Osteogeneration from Adipocytes, and Increased Levels Due to Doxorubicin Exposure|Pharmaceutics|2023|8